Skip to main content
OpenTrials

Clinical trial condition

Advanced Cancers (Breast, Ovarian, mCRPC, Pancreatic Ductal Adenocarcinoma (PDAC), Brain Mets) With Specific Mutations (Homologous Recombination Deficiency)

Explore clinical trials studying Advanced Cancers (Breast, Ovarian, mCRPC, Pancreatic Ductal Adenocarcinoma (PDAC), Brain Mets) With Specific Mutations (Homologous Recombination Deficiency). Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study
Refine in advanced search Browse all conditions

Advanced Cancers (Breast, Ovarian, mCRPC, Pancreatic Ductal Adenocarcinoma (PDAC), Brain Mets) With Specific Mutations (Homologous Recombination Deficiency) trial results

Recruiting

Study to Assess Safety, Tolerability and Activity of DSB2455 in Participants With Advanced Malignancies

NCT06458712

Conditions
Advanced Cancers (Breast, Ovarian, mCRPC, Pancreatic Ductal Adenocarcinoma (PDAC), Brain Mets) With Specific Mutations (Homologous Recombination Deficiency), Anophthalmia with pulmonary hypoplasia, Fanconi Anemia, Complementation Group D1, +1 more
Locations
  • Yale Cancer Center - Yale New Haven Hospital New Haven, Connecticut, United States
  • Tisch Cancer Institute Icahn School of Medicine at Mount Sinai New York, United States
  • The University of Texas M. D. Anderson Cancer Center Houston, Texas, United States
  • Institut Bergonie Bordeaux, France
View all 18 locations
View Trial Details

Related conditions